Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 3
    Unavailable
    Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 3
    Unavailable
    Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 3
    Ebook875 pages10 hours

    Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 3

    By Vearsa Limited

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect.

    LanguageEnglish
    PublisherVearsa Limited
    Release dateMay 31, 2016
    ISBN9781681082899
    Unavailable
    Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 3

    Related to Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 3

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Weight-loss Drug Could Fight Resistant Lung Cancer

      Aug 5, 2018

      New research could pave the way for using versions of an existing drug to keep lung cancer cells from becoming drug-resistant. Researchers have discovered that a key enzyme in lipid metabolism controls the response to a class of targeted drugs called

      2 min read

    • Article

      How Breast Cancer Hijacks Immune Cells To Weaken Our Defense

      Jun 6, 2018

      Researchers have discovered that tumor cells reprogram metabolic pathways to gain control over a type of immune cell that allows cancer growth. Myeloid-derived suppressor cells live in the tumor microenvironment and work to block cancer immunity. The

      1 min read

    • Article

      Broccoli-Based Compound May Treat Melanoma

      Jul 25, 2017

      A new compound may lead to a drug that can destroy melanoma cancer cells while leaving nearby healthy cells unharmed, new research on mice and human cells indicates. …the compound caused human melanoma cells to die and inhibited tumor growth by about

      2 min read

    • Article

      How Cellular Pumps Protect The Gut From Toxic Stuff

      Oct 9, 2018

      The master regulators of gut stem cells, called intestinal myofibroblasts, have pumps that protect them, and therefore the gut, from the toxic effects of a wide range of compounds, including the anticancer drug tamoxifen, according to new research. “

      2 min read

    • Article

      Could A Drug One Day Block Harmful Stress Responses?

      Jan 29, 2024

      New research could pave the way for new, more specific treatments for stress-​related conditions such as chronic depression with fewer side effects. Stress isn’t merely an oppressive feeling we experience when we’re overwhelmed; it’s the body’s natur

      3 min read

    • Article

      Injectable Goo Could Bring Drugs To Cancerous Tumors

      Feb 22, 2018

      An injectable gel-like scaffold can hold combination chemo-immunotherapeutic drugs and deliver them locally and sequentially to tumors. The results in animal models so far suggest this approach could eventually ramp up therapeutic benefits for patien

      3 min read

    • Article

      ‘Assassin’ Molecules Drive Cancer Cells to Self-Destruct

      Oct 20, 2017

      Research finds that certain small RNA molecules can trigger a mechanism hidden in every cell that forces it to self-destruct. This failsafe may protect us from cancer. “This could be a major breakthrough…” The mechanism could potentially become a nov

      3 min read

    • Article

      Types Of Immunotherapy

      Jul 30, 2020

      It’s worth noting that you might hear the same drug or treatment called different things. For example, a type of immunotherapy called checkpoint inhibitors, is also described as a monoclonal antibody or targeted treatment. ✢ These mimic natural anti

      1 min read

    • Article

      The Best Integrative Cancer Specialists

      Nov 21, 2021

      The Best Integrative Cancer Specialists
      5 min read

    • Article

      Team Discovers Roughly 100 Potential Cancer Culprits

      May 14, 2018

      Researchers have uncovered a number of proteins that could play a critical role propagating signals within cells that can lead to uncontrolled cell growth—one of the hallmarks of cancer. The study, which appears in Cell Reports, used mouse fibroblast

      2 min read

    • Article

      Opinion: Drug Sensitivity And Resistance Testing Could Make ‘Right To Try’ A Real Thing

      Oct 9, 2018

      There's no catalog of available drugs that can help patients pursuing #RightToTry options. An updated technique once developed for cancer might match patients with experimental drugs.

      3 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Cancer Care

      Jul 25, 2023

      With bispecific antibody immunotherapy, some physicians are hoping to change the face of cancer care. Dr. Mark J. Fesler (p. 80), a hematologic malignancy specialist with St. Luke's and a board of trustees member for the Leukemia and Lymphoma Society

      1 min read

    • Article

      Machine Learning Predicts How Drugs Will Affect Cancer Cells

      Oct 6, 2023

      A new approach can predict how individual cells react to specific treatments, offering hope for more accurate diagnoses and therapeutics. Cancer is triggered by changes in cells that lead to the proliferation of pathogenic tumor cells. In order to fi

      3 min read

    • Article

      Drug and Gene Therapy Combo May Reverse M.S.

      Sep 22, 2017

      A new gene therapy could inhibit or reverse multiple sclerosis, new research using mouse models suggests. By combining a brain-protein gene and an existing medication, the researchers were able to prevent the mouse version of multiple sclerosis. Like

      2 min read

    • Article

      BPA May Nudge Breast Cancer Cells to Grow

      Mar 31, 2017

      The chemical bisphenol A, or BPA, appears to aid the survival of inflammatory breast cancer cells, according to research that reveals a potential mechanism for how the disease grows. Inflammatory breast cancer (IBC) is the most lethal and fastest-gro

      2 min read

    Reviews for Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 3

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words